You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》心通醫療(02160.HK)公開超購768倍及上限定價 一手中籤率7.5%
阿思達克 02-03 09:02
由微創醫療(00853.HK)分拆旗下微創心通醫療科技(02160.HK)公布招股結果,計劃發售2.06億股股份,當中10%在港公開發售,公開發售錄超購768倍,經重新分配後,公開發售股數增至50%。國際發售項下初步提呈發售的發售股份已獲超額認購54倍以上。

每股發售價定於12.2元,為上限定價(招股價介乎11.1至12.2元),每手1,000股,中籤率為7.5%。該股將於明日(4日)上市。摩根大通、花旗及中金為聯席保薦人。

微創心通醫療是次引入16名基石投資者,已認購7,943.3萬股發售股份,相當於緊隨全球發售完成後公司已發行股本約3.4%。

公司預計集資淨額為23.56億元,當中30%將用於核心產品VitaFlow II;27%將用於現有產品管線的其他產品;3.4%將用於首款商業化TAVI產品VitaFlow;15%將用於通過併購、授權引進安排或股權投資與包括醫療器械企業及研究機構在內的全球賦能者合作擴展集團產品組合提供資金;14.6%將用於擴大產能並提高生產VitaFlow及VitaFlow II的能力;10%將作營運資金及一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account